Latest Articles
-
PQA Appoints 18 Individuals to Serve on Heart Failure TEP
PQA has appointed 18 individuals to serve on a measure development technical expert panel (TEP) to support the development of a new health plan measure: Evidence of Guideline-Directed Medical Therapy in Persons with Heart Failure. This measure will assess the percentage of individuals with prescription claims for guideline-directed medical therapies for the treatment of heart failure. PQA identified heart failure […] -
Enduring Partners in Quality: PQA’s Founding and Original Members
The Pharmacy Quality Alliance was born from a collaboration. In 2006, when Medicare Part D was launched, Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan had a vision to not simply cover seniors’ medication costs, but to pay for high value-care. McClellan’s vision included a public-private partnership – with diverse stakeholders from across health care – that would develop quality measures to help evaluate the Part D program and incentivize plan participants in value-based care. To build the partnership, […] -
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
-
PQA Presents Quality Awards to 10 Medicare Plan Contracts for High Achievement in Medication Quality Measures
Awards Honor Excellence and Improvement in Overall CMS Medicare Part D Star Ratings and PQA Medication Measures Alexandria, Va. (April 14, 2026) – The Pharmacy Quality Alliance (PQA) has recognized 10 Medicare plan contracts with a PQA Laura Cranston Excellence in Quality or Quality Improvement Award for high achievement or significant improvement in PQA measures of […] -
Assessing the Evidence to Support New MTM Quality Measures
When quality measures are used for performance comparisons within national programs, they should meet the measure evaluation criteria of importance, feasibility, scientific acceptability and usability. To satisfy importance criterion, evidence should demonstrate that the process of care meaningfully affects the desired outcome. PQA upholds these established standards for performance measure development, including sufficient evidence of the impact of the process of care on the desired outcome. Researchers at PQA reviewed evidence focusing on the impact on outcomes from the Medicare Part D MTM program or services such as […] -
Five for Friday April 10: Celebrating Success in Advancing Medication Use Quality
The 2026 PQA Annual Meeting is less than six weeks away, and we are excited to welcome you all back to Baltimore to celebrate 20 years of quality. Every speaker for the meeting is confirmed. Our sessions will cover timely topics, including GLP-1s, oncology, pharmacy access, clinical documentation for VBAs, and what’s next for the Star Ratings. […] -
Year One Progress on Identifying Methodologies for Adherence or Persistence to Oral Anticancer Medications
The quality of oral anticancer medication (OAM) use impacts clinical care, care coordination, patient safety, and outcomes, including disparities in care, patient and caregiver experience, population health, and total health care costs. To monitor the quality of OAM use, measures assessing the degree to which patients take OAMs as prescribed was the number one measurement priority rated by 23 national experts and patients convened by PQA […] -
Improving Patient Outcomes Through Pharmacy Models, Such As The Appointment- Based Model
This guest blog is one in a series by sponsors of the PQA Annual Meeting on improving patient outcomes through pharmacy models. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor. The Challenge of Polypharmacy and NonadherenceAs patients age, chronic health conditions tend to accumulate, leading to polypharmacy. Polypharmacy is […] -
Volunteer Service Made PQA’s Launch and Sustained Success Possible
PQA is celebrating its 20th year in 2026. In addition to special events at the 2026 PQA Annual Meeting in Baltimore, Md., May 12-14, PQA will recognize across the year the people, milestones and achievements that have defined the organization’s success. We also will look to the future and PQA’s continuing work to improve the quality of medication use. Over the last 20 years, hundreds of […] -
Ensuring Safe, Responsible and Patient-Centered Use of AI
Artificial intelligence (AI) is reshaping health care, including how medications are used. On November 13, 2025, PQA hosted PQA Convenes: Artificial Intelligence in Medication Use Quality to bring together PQA members, health technology leaders, and other stakeholders for a discussion on how AI and machine learning are being used to identify, understand, and engage patients in their medication […]
PQA In the News
-
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
-
Pharmacy Quality Alliance Elects 2026 Board of Directors and Executive Committee
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality
“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Strategic Media Partnerships
PQA partners with a variety of media to provide news, insights and opinions.
Stay Informed
Get the latest PQA news and events delivered to your inbox.